[1. Mehta M, et al.: Prevalence and antibiotic susceptibility pattern of multi-drug resistant Escherichia coli isolates from urinary tract infection (UTI) patients. Int J Life Sci Pharm Res. 2;6:2012.]Search in Google Scholar
[2. Gerasimovska V, Gerasimovska-Kitanovska B: Extended spectrum beta-lactamase (ESBL) strains of E. coli as a cause of urinary tract infections in hospitalized patients. Antimicrobial Resistance and Infection Control. 4;P121:2015.10.1186/2047-2994-4-S1-P121]Search in Google Scholar
[3. Noor N, et al.: Urinary tract infections associated with multidrug resistant enteric bacilli: characterization and genetical studies. Pak J Pharm Sci. 17;115:2004.]Search in Google Scholar
[4. Dehbanipour R, et al.: High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. Journal of Natural Science, Biology, And Medicine. 7;22:2016.10.4103/0976-9668.175020478016127003964]Search in Google Scholar
[5. Jan N, et al.: Plasmid profile analysis of multidrug resistant E. coli isolated from UTI patients of Nagpur City, India. Romanian Biotechnological Letters. 14;4635:2009.]Search in Google Scholar
[6. Mansouri S, Abbasi S: Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta-lactamase producing Enterobacteriaceae in Southeast Iran. Iranian Journal of Medical Sciences. 35;101:2015.]Search in Google Scholar
[7. Mana Baziboron, et al:Extended Spectrum Beta Lactamase Producing Escherichia Coli and Klebsiella Isolates in Patients with Urinary Tract Infection and Their Antibiotic Susceptibility Pattern in Babol, Northern Iran. International Journal of Advanced Biotechnology and Research. 8;1451:2017]Search in Google Scholar
[8. MH S, MK SY: The prevalence of extended-spectrum beta-lactamases and CTX-M-1 producing Escherichia coli in urine samples collected at Tabriz city Hospitals. Tehran University Medical Journal TUMS Publications. 69;273:2011.]Search in Google Scholar
[9. Ghafourian S, et al.: Incidence of extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae in patients with urinary tract infection. Sao Paulo Medical Journal. 130;37:2012.10.1590/S1516-3180201200010000722344358]Search in Google Scholar
[10. Mohajeri P, et al.: Assessment of the frequency of Extended Spectrum Beta Lactamases Producing Escherichia coli Isolated from Urinary Tract Infections and its Antibiotic Resistance Pattern in Kermanshah. Journal of Ardabil University of Medical Sciences. 11;86:2011.]Search in Google Scholar
[11. Hasan AS, et al.: Resistance patterns of urinary isolates in a tertiary Indian hospital. J Ayub Med Coll Abbottabad. 19;39:2007.]Search in Google Scholar
[12. Dalela G, et al.: Antibiotic resistance pattern in uropathogens at a tertiary care hospital at Jhalawar with special reference to Esbl, Ampc β-Lactamase and MRSA production. J Clin Diagn Res. 6;51:2012.]Search in Google Scholar
[13. Tille P . China: Elsevir Health Sciences; 2013. Bailey & Scott`s Diagnistic Microbiology.]Search in Google Scholar
[14. Hombach M, et al.: Standardisation of disk diffusion results for antibiotic susceptibility testing using the sirscan automated zone reader. BMC Microbiology. 13;225:2013.10.1186/1471-2180-13-225385224824099061]Search in Google Scholar
[15. Bader MS, et al.: An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgraduate Medicine. 129;242:2017.10.1080/00325481.2017.124605527712137]Search in Google Scholar
[16. Azap O, et al.: Risk factors for extended‐spectrum β‐lactamase positivity in uropathogenic Escherichia coli isolated from community‐acquired urinary tract infections. Clinical Microbiology and Infection. 16;147:2010.10.1111/j.1469-0691.2009.02941.x19689464]Search in Google Scholar
[17. Shiva Hashemi, et al.:Irrational antibiotic prescribing: a local issue or global concern? Excli Journal. 12;384:2013]Search in Google Scholar
[18. Shakya P, et al.: ESBL Production Among E. coli and Klebsiella spp. Causing Urinary Tract Infection: A Hospital Based Study. The Open Microbiology Journal. 11;23:2017.10.2174/1874285801711010023542768728553414]Search in Google Scholar
[19. Akram M, et al.: Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Annals of Clinical Microbiology and Antimicrobials. 6;4:2007.10.1186/1476-0711-6-4185232417378940]Search in Google Scholar
[20. Moayednia R, et al.: Frequency assessment of β-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 19;S41:2014.]Search in Google Scholar
[21. D. Chervet, et al.:Antimicrobial resistance in community-acquired urinary tract infections in Paris. Medecine et Maladies Infectieuses. 2017.10.1016/j.medmal.2017.09.01329054298]Search in Google Scholar
[22. Pourakbari B, et al.: Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young patients from Iran. Brazilian Journal of Microbiology. 43;766:2012.10.1590/S1517-83822012000200041376881224031888]Search in Google Scholar
[23. Eslami G, et al.: Epidemiology of extended spectrum beta lactamases producing E. coli genes in strains isolated from children with urinary tract infection in north of Iran. Journal of Mazandaran University of Medical Sciences. 25;270:2016.]Search in Google Scholar
[24. Fahad A, et al.: Incidence and molecolar characterization of the extended spectrum beta lactamase-producing Escherichia coli isolated from urinary tract infections in Eastern Saudi Arabia. Saudi Med J. 38;811:2017.10.15537/smj.2017.8.18578555629728762433]Search in Google Scholar
[25. Nisel Yilmaz, et al.:Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014). Turk J Urol. 42;32:2016.10.5152/tud.2016.90836479107927011879]Search in Google Scholar
[26. Smita Sood and Ravi Gupta: Antibiotic Resistance Pattern of Community Acquired Uropathogens at a Tertiary Care Hospital in Jaipur, Rajasthan. Indian J Community Med. 37;39:2012.10.4103/0970-0218.94023332680622529539]Search in Google Scholar
[27. Hassan SA, et al.: Occurrence of multidrug resistant and ESBL producing E. coli causing urinary tract infections. J Basic Appl Sci. 7;39:2011.]Search in Google Scholar
[28. Trupti Bajpai, et al.: Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empirical therapy. Indian Journal of Pathology and Microbiology. 57;407:2014.10.4103/0377-4929.13873325118732]Search in Google Scholar
[29. Pouladfar G, et al.: The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz. Medicine. 96:2017.10.1097/MD.0000000000007834560463428906365]Search in Google Scholar
[30. Goncalves LF, et al.: Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil. Journal of global antimicrobial resistance. 6;1:2016.10.1016/j.jgar.2016.02.00327530830]Search in Google Scholar
[31. Hossein Khalili, et al.: Adherence to Empirical Antibiotic Therapy Guideline in a Refferal Teaching Hospital, Tehran, Iran. Acta Medica Iranica.50;47:2020.]Search in Google Scholar
[32. Bahman Haghighi, et al.: Comparison of 3-day and 7-day ciprofloxacin regimen for the treatment of uncomplicated urinary tract infection in women: A randomized double-blind clinical trial. Iranian Journal of Clinical Infectious Diseases. 5;70:2010.]Search in Google Scholar
[33. Jin Ju Park, et al.:Antimicrobial susceptibilities of Entrobacteriaceae in Community-Acquired Urinary Tract Infections during a 5-year Period: A Single Hospital Study in Korea. Infect Chemother. 49;184:2017.10.3947/ic.2017.49.3.184562038529027385]Search in Google Scholar
